Table 1 Clinical characteristic of included studies (49 prevalence studies)
Major complication (WHO, 2014) | Total patients with severity sign | Severity rate (%) Total P.vivax, 42,325 cases |
|---|---|---|
Respiratory distress | 566 | 1.34 |
Acidosis | 44 | 0.10 |
Pulmonary edema | 126 | 0.30 |
Death | 152 | 0.36 |
Cerebral malaria | 471 | 1.11 |
Convulsion | 75 | 0.18 |
ARF | 355 | 0.84 |
Prostration | 26 | 0.06 |
Hypotension/shock | 267 | 0.63 |
Jaundice | 634 | 1.50 |
Severe anemia | 1001 | 2.37 |
Bleeding/DIC | 242 | 0.57 |
Hyperparasitemia | 31 | 0.07 |
Hypoglycemia | 65 | 0.15 |
Minor complication | ||
 Hyperpyrexia | 57 | 0.13 |
 Severe vomiting | 139 | 0.33 |
 Drowsiness | 123 | 0.29 |
 Hepatitis | 308 | 0.73 |
 Respiratory (NS*) | 1 | 0.00 |
 Severe vomiting | 1 | 0.00 |
 Sudden cardiac arrest | 7 | 0.02 |
 Hemoglobinuria/Hematuria | 143 | 0.34 |
 Anemia | 1008 | 2.38 |
 Thrombocytopenia | 1243 | 2.94 |